ProShare Advisors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.2K | Sell |
|
|||||
|
2025
Q1 | $30K | Sell |
|
|||||
|
2024
Q4 | $41K | Sell |
|
|||||
|
2024
Q3 | $45.3K | Sell |
|
|||||
|
2024
Q2 | $53.7K | Sell |
|
|||||
|
2024
Q1 | $92.9K | Buy |
|
|||||
|
2023
Q4 | $106K | Sell |
|
|||||
|
2023
Q3 | $87K | Buy |
|
|||||
|
2023
Q2 | $121K | Sell |
|
|||||
|
2023
Q1 | $334K | Sell |
|
|||||
|
2022
Q4 | $510K | Buy |
|
|||||
|
2022
Q3 | $463K | Buy |
|
|||||
|
2022
Q2 | $484K | Buy |
|
|||||
|
2022
Q1 | $287K | Sell |
|
|||||
|
2021
Q4 | $567K | Buy |
|